Cargando…
Rapid response to systemic bevacizumab therapy in recurrent respiratory papillomatosis
Recurrent respiratory papillomatosis (RRP) is a primary benign disease, which is characterized by papillomatous growth in the respiratory tract. Malignant transformation occurs in only 3–5% of cases, however, local growth of the benign papillomas is interpreted as clinically malignant in a markedly...
Autores principales: | MOHR, MICHAEL, SCHLIEMANN, CHRISTOPH, BIERMANN, CHRISTOPH, SCHMIDT, LARS-HENNING, KESSLER, TORSTEN, SCHMIDT, JOACHIM, WIEBE, KARSTEN, MÜLLER, KLAUS-MICHAEL, HOFFMANN, THOMAS K., GROLL, ANDREAS H., WERNER, CLAUDIUS, KESSLER, CHRISTINA, WIEWRODT, RAINER, RUDACK, CLAUDIA, BERDEL, WOLFGANG E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186578/ https://www.ncbi.nlm.nih.gov/pubmed/25289079 http://dx.doi.org/10.3892/ol.2014.2486 |
Ejemplares similares
-
Thoracic Malignancies and Pulmonary Nodules in Patients under Evaluation for Transcatheter Aortic Valve Implantation (TAVI): Incidence, Follow Up and Possible Impact on Treatment Decision
por: Schmidt, Lars Henning, et al.
Publicado: (2016) -
Potential therapeutic impact of CD13 expression in non-small cell lung cancer
por: Schmidt, Lars Henning, et al.
Publicado: (2017) -
Correction: Potential therapeutic impact of CD13 expression in non-small cell lung cancer
por: Schmidt, Lars Henning, et al.
Publicado: (2017) -
Future Options of Molecular-Targeted Therapy in Small Cell Lung Cancer
por: Schulze, Arik Bernard, et al.
Publicado: (2019) -
Systemic Bevacizumab for Severe Recurrent Respiratory Papillomatosis
por: Tatineni, Swetha, et al.
Publicado: (2022)